https://doi.org/10.4081/monaldi.2024.3033
Respiratory rate-oxygenation index on the 3rd day is the best predictor of treatment failure in COVID-19 patients
Accepted: September 17, 2024
SUPPLEMENTARY MATERIAL: 7
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Predictors of outcomes are essential to identifying severe COVID-19 cases and optimizing treatment and care settings. The respiratory rate-oxygenation (ROX) index, originally introduced for predicting the failure of non-invasive support in acute hypoxemic respiratory failure (AHRF), has not been extensively studied over time during hospitalization. This multicenter prospective observational study analyzed COVID-19-related AHRF patients admitted to eight Italian hospitals during the second pandemic wave. The study assessed the ROX index using receiver operator characteristic curves and areas under the curve with 95% confidence intervals to predict treatment failure, defined as endotracheal intubation (ETI) or death. A total of 227 patients (69.2% males) were enrolled, with a median arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2) ratio at admission of 248 (interquartile range: 170-295). Nearly one-third (29.5%) required ETI or died during hospitalization. Those who experienced treatment failure were older (median age 70 versus 61 years, p<0.001), more likely to be current or former smokers (8.5% versus 6.4% and 42.4% versus 25.5%, p=0.039), had a higher prevalence of cardiovascular diseases (74.6% versus 46.3%, p<0.001), and had a lower PaO2/FiO2 ratio at presentation (median 229 versus 254, p=0.014). Gender, body mass index, and other comorbidities showed no significant differences. In patients who failed treatment, the ROX index was higher at presentation and worsened sharply by days 3 and 4. Conversely, in patients who survived without requiring ETI, the ROX index remained stable and reduced after 5-6 days. The ROX index's predictive ability improved notably by the third day of hospitalization, with the best cut-off value identified at 8.53 (sensitivity 75%, specificity 68%). Kaplan-Meier curves indicated that a ROX index of 8.53 or lower on days 1, 2, or 3 was associated with a higher risk of treatment failure. Thus, a single ROX index assessment on day 3 is more informative than its variability over time, with values of 8.53 or lower predicting non-invasive respiratory support failure in hospitalized COVID-19 patients.
Ethics Approval
This study was approved by the respective ethics committees involved (Comitato etico di Bergamo - n.308-20, 05/02/2021; Comitato etico della Brianza - EC approval on 02/04/2021; Comitato etico di Ferrara - n.373/2021/Oss/AOUFe, 22/04/2021; Comitato etico Ospedale Sacco Milano - n.2021/ST/091, 19/04/2021; Comitato etico di Palermo - n.3/2021, 31/03/2021; Comitato etico Policlinico Milano - n.433/2021, 23/04/2021; Comitato etico San Paolo Milano - n.965, 21/04/2021; Comitato etico di Verona - n.3171CESC, 11/03/2021).How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Sara Salim Ali, Imran Ahmed Qureshi, Ahmed Ayaz, Ainan Arshad, Awais Farhad, Bushra Jamil, Muhammad Rizwan Sohail, Etiology, clinical characteristics, and outcome of infective endocarditis: 10-year experience from a tertiary care center in Pakistan , Monaldi Archives for Chest Disease: Vol. 92 No. 4 (2022)
- Danish Abdul Aziz, Muhammad Aqib Sajjad, Haissan Iftikhar, Clinical outcomes of children with acute asthma managed with intravenous magnesium sulphate outside intensive care setting , Monaldi Archives for Chest Disease: Early Access
- Nousheen Iqbal, Iffat Khanum, Muhammad Ali Ibrahim Kazi, Syeda Urooj Riaz, Uzzam Ahmed Khawaja, Safia Awan, Muhammad Irfan, Ali Bin Sarwar Zubairi, Javaid Ahmed Khan, Post-COVID-19 sequelae of the respiratory system. A single-centre experience reporting the compromise of the airway, alveolar and vascular components , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Madoka Ito, Naoto Ishimaru, Toshio Shimokawa, Yoshiyuki Kizawa, Risk factors for mortality in aspiration pneumonia: a single-center retrospective observational study , Monaldi Archives for Chest Disease: Vol. 93 No. 3 (2023)
- Kapil Kumar, Prem Parkash Gupta, Arvind Kumar Verma, Rohtas Yadav, Assessment of prevalence and characteristics of asthma-COPD overlap among patients with chronic airflow obstruction , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Guido Levi, Marco Umberto Scaramozzino, Stefania Cavallo, Giuliano Castignini, Michela Bezzi, Laura Pini, Frank Nania, Sheenam Sheenam, Pulmonary rehabilitation improves functional outcomes and quality of life in post-SARS-CoV-2 mild-to-moderate infection patients: a pilot study , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
- Marco Umberto Scaramozzino, Guido Levi, Ubaldo Romeo Plastina, Giovanni Sapone, A rare case of asthmatic patient with left Chilaiditi’s syndrome , Monaldi Archives for Chest Disease: Early Access
- A.L. Kruis, N.H. Chavannes, Potential benefits of integrated COPD management in primary care , Monaldi Archives for Chest Disease: Vol. 73 No. 3 (2010): Pulmonary series
- Mahmood Shirzad, Abbasali Karimi, Seyed Hossein Ahmadi, Mehrab Marzban, Mokhtar Tazik, Hermineh Aramin, Predictors and Early Outcome of Prolonged Mechanical Ventilation in Contemporary Heart valve Surgery , Monaldi Archives for Chest Disease: Vol. 74 No. 1 (2010): Cardiac series
- H.J.C. Bonestroo, M.G. Slieker, H.G.M. Arets, No positive effect of rhdnase on the pulmonary colonization in children with cystic fibrosis , Monaldi Archives for Chest Disease: Vol. 73 No. 1 (2010): Pulmonary series
<< < 39 40 41 42 43 44 45 46 47 48 > >>
You may also start an advanced similarity search for this article.
